Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review

Date: July 18, 2017
Pages: 53
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B3FC36BBC60EN
Leaflet:

Download PDF Leaflet

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review
Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Biocon Ltd (Biocon) is a global biopharmaceutical company specialized in biopharmaceuticals and research services. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. Its core therapeutic areas include diabetes, cancer and autoimmune conditions. The company also provides research services which include discovery, development and manufacturing services for both small and large molecules. Biocon caters its research and development solutions to the biotechnology and pharmaceutical companies across the world. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Biocon is headquartered in Bangalore, Karnataka, India.

Biocon Ltd Key Recent Developments

Jul 09,2017: Biocon provides update on Bangalore Facility
Jul 09,2017: Biocon Receives GMP approval for Biologics Drug Substance facilities from French Regulator; Drug Product facility to be re-inspected
Jul 09,2017: Biocon: Update on Inspection Audits by French health agency
Jun 05,2017: Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation
May 10,2017: Biocon statement in response to media reports on USFDA Form 483s for Biocon Limited

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Biocon Ltd - Key Facts
Biocon Ltd - Key Employees
Biocon Ltd - Key Employee Biographies
Biocon Ltd - Major Products and Services
Biocon Ltd - History
Biocon Ltd - Company Statement
Biocon Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Biocon Ltd - Business Description
Biocon Ltd - SWOT Analysis
SWOT Analysis - Overview
Biocon Ltd - Strengths
Biocon Ltd - Weaknesses
Biocon Ltd - Opportunities
Biocon Ltd - Threats
Biocon Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Biocon Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 09, 2017: Biocon Receives GMP approval for Biologics Drug Substance facilities from French Regulator; Drug Product facility to be re-inspected
Jul 09, 2017: Biocon: Update on Inspection Audits by French health agency
Jul 09, 2017: Biocon provides update on Bangalore Facility
Jun 05, 2017: Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation
May 10, 2017: Biocon statement in response to media reports on USFDA Form 483s for Biocon Limited
May 05, 2017: Biocon: Company Statement Media Reports on USFDA 483s
Apr 27, 2017: Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue at Rs 4,079 Cr; Net Profit at Rs 612 Cr
Jan 25, 2017: Biocon Wins MYR 300 Million Contract for Insulin from MoH, Malaysia
Jan 25, 2017: Biocon Announces Changes of Key Managerial Personnel
Jan 24, 2017: Biocon Q3 FY17 Net Profit Up 65% at Rs 171 Crore

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Biocon Ltd, Key Facts
Biocon Ltd, Key Employees
Biocon Ltd, Key Employee Biographies
Biocon Ltd, Major Products and Services
Biocon Ltd, History
Biocon Ltd, Subsidiaries
Biocon Ltd, Joint Venture
Biocon Ltd, Key Competitors
Biocon Ltd, Ratios based on current share price
Biocon Ltd, Annual Ratios
Biocon Ltd, Annual Ratios (Cont...1)
Biocon Ltd, Annual Ratios (Cont...2)
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Biocon Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Biocon Ltd, Performance Chart (2013 - 2017)
Biocon Ltd, Ratio Charts
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Biocon Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sun Pharmaceutical Industries Ltd
Sun Pharma Advanced Research Company Ltd
Serum Institute of India Ltd
Piramal Enterprises Ltd
Panacea Biotec Ltd
Morepen Laboratories Ltd
Dr. Reddy's Laboratories Ltd
Bharat Immunologicals and Biologicals Corp Ltd
Abeona Therapeutics Inc
Skip to top


Ask Your Question

Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: